Arthritis, Musculoskeletal and Skin Diseases Research in Virginia
Arthritis, Musculoskeletal and Skin Diseases Research (93.846) awarded $39.5 million to recipients in Virginia in 46 grants from fiscal 2021 to 2025, 1.5% of the program's national total. Rector & Visitors of the University of Virginia received the most, $17.1 million.
- Awarded in Virginia$39.5 million
- Awards46
- Share of the program1.5%
- Rank among states17th of 44
- National total$2.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 18 | $6.2 million |
| FY 2022 | 22 | $7.9 million |
| FY 2023 | 23 | $7.3 million |
| FY 2024 | 18 | $7.3 million |
| FY 2025 | 21 | $10.9 million |
Recipients in Virginia
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Rector & Visitors of the University of Virginia | Colleges and universities | 16 | $17.1 million |
| Virginia Polytechnic Institute & State University | Colleges and universities | 9 | $8.4 million |
| Virginia Commonwealth University | Other | 10 | $6.9 million |
| Biotherapeutics, Inc. | Small businesses | 4 | $2.7 million |
| Springbok Inc | Small businesses | 2 | $1.9 million |
| Rivanna Medical, Inc. | Small businesses | 2 | $1.6 million |
| Orthopreserve, Inc. | Small businesses | 1 | $303,905 |
| Marymount University | Colleges and universities | 1 | $250,304 |
| Asante Bio LLC | Small businesses | 1 | $247,705 |
Open opportunities under this program
- HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed)
- NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
- Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)
- Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed)
See all 60 on the program page
Questions people ask
How much Arthritis, Musculoskeletal and Skin Diseases Research money goes to Virginia?
$39.5 million from fiscal 2021 to 2025, across 46 awards. Virginia ranks 17th of 44 states and territories for this program.
Who receives Arthritis, Musculoskeletal and Skin Diseases Research money in Virginia?
The largest recipient is Rector & Visitors of the University of Virginia, with $17.1 million in 16 awards. Next are Virginia Polytechnic Institute & State University and Virginia Commonwealth University.
Can organizations in Virginia apply now?
Yes, 60 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Arthritis, Musculoskeletal and Skin Diseases Research in other states
Other large programs in Virginia
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Children's Health Insurance Program
- Special Education Grants to States
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- Broadband Equity, Access, and Deployment Program
- Emergency Food and Shelter National Board Program